Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Sep 27, 2010 11:37am
326 Views
Post# 17496251

Whats next

Whats nextIts interesting because someone sent me a message over the past week and commented that they thought I was done posting on the site. I thought I would explain;  several years ago I consulted for Diagnocure and was able to get both Gen-Probe and Diagnocure into the hospital where I was working to meet with key decision makers from both the Urology and Colorectal departments.
     I picked a key member from Diagnocure up from the airport and spent the day touring the lab and meeting with physicians from both departments. It was an eye opening experience especially from the colorectal side, learning how they handle the lymph nodes after the procedure. I realized how much GCC would help throughout this entire process. PCA3 was an easy sell and as I have pointed out in the past its being used on a regular basis at this hospital. (it still took a while to go through all the hospital internal approval process.) 
    GCC was also a very easy sell except that the hospital wanted to run the test out of their own lab. Again, this was a one day consult, and it was around 3 yrs ago. It got me excited about the future for Diagnocure so I spent much of my time discussing the markers with just about anyone who would listen.
     I wanted to be a part of the upcoming success. So what I put together was a low key presentation to get local investors excited about this Canadian company. Not small time investors but V.I.P.'s that own national companies. I was able to get two attracted to the story. (the article in the local paper was a key in my discussions, it verified what I had been talking about.)  I am not going to go into alot of details but the first one started in one direction and ended up with the individual looking at acquiring CUR secondary to the drop in the share price.
     The second was the one I worked the longest on and this came about when Diagnocure was looking for a partner for their U.S. lab. I was able to find someone who was willing for starters to invest $10 million in the lab in Philly. Again, this investor, owns several privately held companies in the health care industry. He is aggressive but I felt this would solve their current concerns. I set up several meetings with well known physicians independent from CUR that would help sell the value of GCC. I also gave my opinion that I thought it would be a good idea to start picking up some shares of CUR because with any deal, the share price should make a good move. I called my friends at Diagnocure to arrange the meeting and was excited to hear their response. In the end, CUR put me on hold, and did not want to meet. I have my reasons why but nothing to back them up. 
     What concerns me now is that I went at all this with the best intentions, I wanted to play a small part in the U.S. growth of this company, I wanted to be rewarded for setting up a deal, which was unrealistic, they just wanted the phone # for themselves. In the end, I am just a share holder waiting for approval. My fear is that these individuals or someone else will acquire the company, destroying what we have all been waiting for.

    
Bullboard Posts